Skip to main content
Premium Trial:

Request an Annual Quote

DNAPrint Acquires Kenna Technologies in All-Stock Deal

NEW YORK, Nov. 1 (GenomeWeb News) - DNAPrint Genomics acquired privately held Kenna Technologies in an all-stock transaction, DNAPrint said today.

 

Shareholders of the West Chester, PA-based company exchanged all of their outstanding shares for 1.5 million shares of DNAPrint's common stock. The transaction took effect Oct. 25.

 

With the acquisition, DNAPRint gains Kenna's BoneFusion and CellCycleFusion models. BoneFusion simulates processes in bone remodeling and CellCycleFusion simulates molecular pathways that control basic cellular functions.

 

This is DNAPrint's second major acquisition for the year. The company acquired Trace Genetics in June and 18% of Biofrontera in July.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.